Oragenics Inc (OGEN)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

4902 EISENHOWER BLVD TAMPA, FL 33634

Oragenics, Inc. is focused on the creation of the Terra CoV-2 vaccine candidate to combat the novel coronavirus pandemic and the further development of effective treatments for novel antibiotics against infectious disease. The Company is dedicated to the development and commercialization of a vaccine candidate providing specific immunity from novel coronavirus. The Terra CoV-2 immunization leverages coronavirus spike protein research conducted by the National Institute of Health. In addition, Oragenics has an exclusive worldwide channel collaboration with ILH Holdings, Inc. (n/k/a Eleszto Genetika, Inc.), relating to the development of novel lantibiotics.

Data as of 2021-09-19 12:34:25 -0400
Market Cap74.051 Million Shares Outstanding116.195 Million Avg 30-day Volume1.488 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.19448 52-week High/Low1.8 / 0.377 Next Earnings Date2021-11-10 Price to Cash FLow (P/CF) -23.5932
Data provided by IEX Cloud
View SEC Filings from OGEN instead.

View recent insider trading info

Funds Holding OGEN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding OGEN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TELLING FRED

  • Director
596,078 2021-06-29 3

POPE CHARLES L

  • Director
0 2021-02-18 1

JOSLYN ALAN CEO AND PRESIDENT

  • Officer
  • Director
0 2021-02-18 1

DUNTON ALAN W

  • Director
0 2021-02-18 1

SULLIVAN MICHAEL O'KEEFE CFO, SECRETARY AND TREASURER

  • Officer
0 2021-02-18 1

MURPHY KIMBERLY M

  • Director
0 2021-02-18 1

HERNANDEZ JOSEPH

  • 10% Owner
0 2021-01-04 2

KOSKI ROBERT C

  • Director
1,042,408 2021-01-02 2

KOSKI BEVERLY

  • FORMER 10% OWNER
No longer subject to file 2019-08-09 0

KOSKI CHRISTINE L

  • FORMER 10% OWNER
No longer subject to file 2019-08-09 0

KOSKI FAMILY LP

  • FORMER 10% OWNER
No longer subject to file 2019-08-09 0

KOSKI THOMAS L

  • FORMER 10% OWNER
No longer subject to file 2019-08-09 0

KOSKI ROBERT C

KOSKI CHRISTINE L

KOSKI BEVERLY

KOSKI FAMILY LP

KOSKI THOMAS L

  • Director
  • AFFILIATEAFFILIATEAFFILIATEAFFILIATE
1,869,429 2019-06-20 2

KIRK RANDAL J

INTREXON CORP

  • 10% Owner
15,481,644 2016-06-30 0

BONFIGLIO JOHN N PRESIDENT AND CEO

  • Officer
  • Director
385,255 2014-08-13 0

BOHUNICKY BRIAN JOHN CFO, SECRETARY AND TREASURER

  • Officer
37,800 2011-11-14 0

HILLMAN JEFFREY D CHIEF SCIENTIFIC OFFICER

  • Officer
  • Director
363,128 2011-10-12 0

HAWES GEORGE T

  • 10% Owner
539,397 2010-10-13 0

HIRSCH DAVID BRIAN PRESIDENT AND CEO

  • Officer
  • Director
0 2009-12-01 0

ZAHRADNIK ROBERT T CHIEF OPERATING OFFICER

  • Officer
881,000 2009-03-18 0

DELFINO DOROTHY JEAN CFO AND SECRETARY

  • Officer
0 2008-05-21 0

WELCH RICHARD T.

  • Director
0 2008-05-09 0

HENNECKE DEREK

  • Director
0 2008-05-09 0

SILLS KEVIN H

  • Director
0 2008-05-09 0

SIEGEL MARC K

  • Director
0 2008-05-09 0

STEIN STANLEY BRUCE PRESIDENT & CEO

  • Officer
  • Director
0 2008-04-08 0

GURY DAVID J

  • Director
125,000 2008-02-08 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ORAGENICS INC OGEN 2021-09-27 22:15:03 UTC -6.614 6.684 3000000
ORAGENICS INC OGEN 2021-09-27 21:45:03 UTC -6.614 6.684 3000000
ORAGENICS INC OGEN 2021-09-27 21:15:03 UTC -6.614 6.684 3000000
ORAGENICS INC OGEN 2021-09-27 20:45:04 UTC -6.614 6.684 3000000
ORAGENICS INC OGEN 2021-09-27 20:15:03 UTC -6.614 6.684 3000000
ORAGENICS INC OGEN 2021-09-27 19:45:03 UTC -6.614 6.684 3000000
ORAGENICS INC OGEN 2021-09-27 19:15:03 UTC -6.614 6.684 3000000
ORAGENICS INC OGEN 2021-09-27 18:45:02 UTC -6.614 6.684 3000000
ORAGENICS INC OGEN 2021-09-27 18:15:03 UTC -6.614 6.684 3000000
ORAGENICS INC OGEN 2021-09-27 17:45:03 UTC -6.614 6.684 3000000
ORAGENICS INC OGEN 2021-09-27 17:15:04 UTC -6.614 6.684 2000000
ORAGENICS INC OGEN 2021-09-27 16:45:03 UTC -6.614 6.684 2000000
ORAGENICS INC OGEN 2021-09-27 16:15:03 UTC -6.614 6.684 2000000
ORAGENICS INC OGEN 2021-09-27 15:45:03 UTC -6.614 6.684 2000000
ORAGENICS INC OGEN 2021-09-27 15:15:03 UTC -6.614 6.684 2000000
ORAGENICS INC OGEN 2021-09-27 14:45:02 UTC -6.614 6.684 2000000
ORAGENICS INC OGEN 2021-09-27 14:15:03 UTC -6.614 6.684 2000000
ORAGENICS INC OGEN 2021-09-27 13:45:03 UTC -6.614 6.684 2000000
ORAGENICS INC OGEN 2021-09-27 13:15:03 UTC -6.614 6.684 2000000
ORAGENICS INC OGEN 2021-09-27 12:45:04 UTC -6.614 6.684 2000000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund OGEN -17900.0 shares, $-12628.45 2021-06-30 N-PORT

Elevate your investments